• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

VU0810464 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758761

VU0810464 is a non-ureaG protein-gated inwardly-rectifying potassium channels (GIRK, Kir3) activator. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
VU0810464, Inhibitor
Full Product Name
VU0810464
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
99.73%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
349.83
Solubility
DMSO: 250mg/mL (714.63mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C18H21ClFN3O
SMILES
Cc1cc(NC(=O)Cc2ccc(F)c(Cl)c2)n(C2CCCCC2)n1
CAS Number
2126040-21-7
Target & IC50
GIRK 1/2: ic50 165nM (EC50)
GIRK1/4: ic50 720nM (EC50)

Structure of VU0810464, inhibitor

VU0810464 Inhibitor – Cat# MBS5758761

Product References and Citations for VU0810464, inhibitor

Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators[J]. Acs Chemical Neuroscience, 2017, 8(9):1873-1879.
Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators[J]. Acs Chemical Neuroscience, 2017, 8(9):1873-1879.
Vo BN, et al. VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir 3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir 3 channels and reduces stress-induced hyperthermia in mice. Br J Pharmacol. 2019 Jul;176(13):2238-2249.
Vo BN, et al. VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir 3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir 3 channels and reduces stress-induced hyperthermia in mice. Br J Pharmacol. 2019 Jul;176(13):2238-2249.

Other Notes

Small volumes of VU0810464, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for VU0810464 purchase

MBS5758761 is an inhibitor targeting VU0810464.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000